Literature DB >> 32641591

JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease.

Ryuji Fukazawa1, Junjiro Kobayashi2, Mamoru Ayusawa3, Hiromichi Hamada4, Masaru Miura5, Yoshihide Mitani6, Etsuko Tsuda7, Hiroyuki Nakajima8, Hiroyuki Matsuura9, Kazuyuki Ikeda10, Kazuhiko Nishigaki11, Hiroyuki Suzuki12, Kei Takahashi13, Kenji Suda14, Hiroshi Kamiyama3, Yoshihiro Onouchi15, Tohru Kobayashi16, Hiroyoshi Yokoi17, Kisaburo Sakamoto18, Masami Ochi19, Soichiro Kitamura20,21, Kenji Hamaoka22, Hideaki Senzaki23, Takeshi Kimura24.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32641591     DOI： 10.1253/circj.CJ-19-1094

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  39 in total

1.  Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.

Authors:  Ryusuke Ae; Hiroya Masuda; Taka-Aki Koshimizu; Masami Matsumura; Koki Kosami; Kanako Hayashida; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2021-03-08       Impact factor: 1.655

2.  [Association between duration of fever before treatment and intravenous immunoglobulin resistance in Kawasaki disease].

Authors:  Xin Wang; Si-Lin Pan; Zhan-Hui DU; Zhi-Xian Ji; Gang Luo; Hong-Xiao Sun; Shu-Jing Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-04-15

3.  [Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].

Authors:  Hui-Min Hu; Xiao-Zheng Chen; Yong-Lan Zhang; Zhong-Dong DU
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15

4.  Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Authors:  Seigo Okada; Hiroki Yasudo; Yuji Ohnishi; Chie Matsuguma; Reiji Fukano; Takahiro Motonaga; Takako Waniishi; Shunji Hasegawa
Journal:  Inflammation       Date:  2022-10-08       Impact factor: 4.657

5.  [Pediatric expert consensus on the application of aspirin in Kawasaki disease].

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15

6.  Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease.

Authors:  Yuanzheng Zheng; Saihua Huang; Jialing Zhang; Jia Hou; Fang Wu; Wenji Wang; Xiao Han; Yonghao Gui
Journal:  Cell Prolif       Date:  2022-05-17       Impact factor: 8.755

7.  The relationship between TNF-like protein 1A and coronary artery aneurysms in children with Kawasaki disease.

Authors:  Jing Zhang; Haobo Weng; Qiongfei Pei; Penghui Yang; Wentao Fan; Ruixi Liu; Qijian Yi
Journal:  Clin Exp Med       Date:  2021-07-07       Impact factor: 3.984

8.  Kawasaki Disease Complicated by Late-Onset Fatal Cerebral Infarction: A Case Report and Literature Review.

Authors:  Lin Wang; Hongyu Duan; Kaiyu Zhou; Yimin Hua; Xiaoliang Liu; Chuan Wang
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

9.  Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.

Authors:  Yuji Moritoh; Masahiro Kamada; Shinsaku Matsumoto; Koji Kido
Journal:  Eur Heart J Case Rep       Date:  2021-06-07

10.  Factors affecting the duration of coronary artery lesions in patients with the Kawasaki disease: a retrospective cohort study.

Authors:  Xuting Zhang; Yuee He; Yiping Shao; Biyao Hang; Zhipeng Xu; Maoping Chu
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-26       Impact factor: 3.054
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.